HanchorBio and Taiwan Cancer Moonshot Project Establish Collaboration
HanchorBio and the Taiwan Cancer Moonshot Project are collaborating to advance precision oncology by combining multi-omics research with HanchorBio's immuno-oncology platform.
HanchorBio has entered into a strategic collaboration with the Taiwan Cancer Moonshot Project, specifically with a sub-team led by Professor Sung-Liang Yu.
The partnership aims to accelerate biomarker-driven drug development in oncology. It integrates the multi-omics cancer research expertise from Professor Yu's team with HanchorBio's clinical-stage immuno-oncology platform.
This collaboration focuses on advancing precision oncology and next-generation precision immunotherapy. By identifying patients based on biomarkers, the aim is to develop more targeted and effective cancer treatments.
The alliance leverages internationally recognized cancer research with HanchorBio's technological capabilities. The objective is to enhance the development of targeted therapies for cancer patients, improving treatment outcomes through personalized medicine approaches.